Teleflex Inc. To Present At Social Media And Critical Care Conference (SMACC) In Dublin, Ireland

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, is committed to connecting clinicians with technology in a way that improves clinical practice and advances patient outcomes. Teleflex will present its innovative intraosseous vascular access system, products for rescue airway, atomization and intubation needs at the first Social Media and Critical Care Conference (“SMACC”) in Dublin, Ireland on June 13-16, 2016.

During the event, Teleflex will be part of a global critical care community that has grown from strong social media connections among the delegates aiming at excellence in patient care, innovation, teaching and learning. Teleflex will showcase its Arrow^® EZ-IO^® Intraosseous Vascular Access System and other products for rescue airway, atomization and intubation needs, host a procedural lab and provide lectures at its booth.

The Arrow^® EZ-IO^® Intraosseous Vascular Access System from Teleflex is an innovative and complete solution for rapid vascular access – whether the emergency responder is facing difficult vascular access challenges or the need for fast intraosseous access for critical situations and life-threatening emergencies. This system is designed to provide the medical professional vascular access to the central circulation system within seconds¹, delivering medications, intravenous fluids and blood products to adult and pediatric patients alike.

Teleflex will be sponsoring a procedural lab in partnership with the American College of Emergency Physicians and SMACC. Resuscitation of the critically ill is paramount for optimal patient care and outcome, yet it can be the most stressful and frustrating component of clinical practice. Resuscitation demands excellence in the provision of quality invasive procedures, however, the skills that are required to save a life are often not utilized in a timely, optimal fashion due to lack of practice, unfamiliarity with the procedure itself or advances in equipment or technique. At this procedural lab, internationally renowned instructors will be teaching utilizing actual tissue, making this a low stress learning environment.

The Teleflex Clinical & Medical Affairs team will be at the booth to provide lectures on the latest clinical topics and resuscitation scenarios using high fidelity simulation models in a virtual reality environment. The team of highly experienced clinicians will demonstrate the latest, evidence based interventions related to intraosseous needle placement. These interactive sessions will help educate clinicians from around the globe, advancing clinical practice and improving patient outcomes.

During SMACC, Teleflex will also focus on the new LMA^® Protector™ Laryngeal Mask Airway. The LMA^® Protector™ Airway represents a new chapter in Teleflex’s search for the optimum subglottic airway. With a fully silicone construction, Cuff Pilot™ Technology, dual gastric channels and the ability to intubate, the LMA^® Protector™ Airway is the most advanced second generation airway from Teleflex.

When IV drug delivery is less than ideal, the LMA^® MAD Nasal™ Device² from Teleflex can come to the rescue delivering safe, painless and rapidly effective treatment. No needle. No trauma. No risk of needle stick injury. In addition, Teleflex will introduce a range of laryngoscopes featuring the TruLite Secure™ Single-Use Laryngoscope blade and handle, complementing our existing Anaesthesia portfolio to offer complete airway solutions.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow^®, Deknatel^®, Hudson RCI^®, LMA^®, Pilling^®, Rusch^® and Weck^® – trusted brands united by a common sense of purpose.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management’s current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, the Teleflex logo, Arrow, Deknatel, EZ-IO, Hudson RCI, LMA, LMA Protector, MAD Nasal, Pilling, Rusch, TruLite Secure and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. © 2016 Teleflex Incorporated. All rights reserved.

References:

¹Von Hoff DD , Kuhn JG, Burris HA, Miller LJ. Does intraosseous equal intravenous? A pharmacokinetic study. Amer J Emerg Med 2008;26:31-8

²For use with drugs approved for intranasal delivery